Prostate Cancer Clinical Trials in Kansas City, MO

View the best 10 prostate cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Prostate Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for prostate cancer in Kansas City, Missouri

Enzalutamide +1 More

Antiandrogen

Recruiting1 awardPhase 3

This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1

This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.

Carboplatin +1 More

Alkylating agents

Recruiting1 awardPhase 2

This trial is comparing the efficacy of two treatments for patients with metastatic castrate resistant prostate cancer who have tumors containing BRCA1, BRCA2 or PALB2 inactivating DNA mutations.

Recombinant EphB4-HSA Fusion Protein +1 More

Recruiting1 awardPhase 2

This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.

CAN-2409 Immunotherapy

Cancer Vaccine

Recruiting0 awardsPhase 2

This trial is testing CAN-2409, a treatment that kills prostate cancer cells and boosts the immune system to fight the cancer. It targets patients with localized prostate cancer. The treatment aims to improve their health outcomes by helping their immune system attack the cancer.

Enzalutamide

Antiandrogen

Recruiting1 awardPhase 2

This trial is to study the long-term safety of subjects who are still benefiting from treatment with Enzalutamide.

Enzalutamide

Antiandrogen

Recruiting1 awardPhase 3

This trial is testing a new drug to treat prostate cancer that has not spread. They will be testing how well it works and if it is safe.

AMG 509

Protein Kinase Inhibitor

Recruiting1 awardPhase 1

This trial is testing a new drug called AMG 509 in adults to see if it is safe and to find the best dose. The study will monitor how people react to different doses.

Hypofractionated Radiation

Radiation Therapy

Recruiting1 award

This trial is testing if a new way of treating prostate cancer, ultra-hypofractionation, is effective and has less urinary side effects.

MRT-2359

Molecular Glue Degrader

Recruiting1 awardPhase 1 & 2

This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.

Popular Filters

Phase 3 Trials

Antiandrogen

Enzalutamide + Leuprolide for Prostate Cancer

Recruiting1 awardPhase 3

Westwood, Kansas

This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.

Antiandrogen

Enzalutamide for Prostate Cancer

Recruiting1 awardPhase 3

Overland Park, Kansas

This trial is testing a new drug to treat prostate cancer that has not spread. They will be testing how well it works and if it is safe.

Antiandrogen

Apalutamide for Castration-Resistant Prostate Cancer

Recruiting1 awardPhase 3

Westwood, Kansas

This trial will test whether apalutamide can help treat prostate cancer that is not responding to hormone therapy and has not spread.

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

Recruiting2 awardsPhase 3

Jonesboro, Arkansas

This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.

Corticosteroid

Hormone + Radiation Therapy with TAK-700 for Prostate Cancer

Recruiting2 awardsPhase 3

Kansas City, Missouri

This trial is studying the use of hormone therapy, including TAK-700, together with radiation therapy to see how well it works in treating patients with prostate cancer.

PARP Inhibitor

Talazoparib + Enzalutamide for Prostate Cancer

Recruiting1 awardPhase 3

Fairway, Kansas

This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.

Trials With No Placebo

Antiandrogen

Enzalutamide + Abiraterone + Prednisone for Prostate Cancer

Recruiting1 awardPhase 2

Kansas City, Kansas

This trial is to study the long-term safety of subjects who are still benefiting from treatment with Enzalutamide.

Checkpoint Inhibitor

Nivolumab + Ipilimumab for Rare Cancers

Recruiting1 awardPhase 2

Fort Smith, Arkansas

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

sEphB4-HSA + Pembrolizumab for Cancer

Recruiting1 awardPhase 2

Kansas City, Kansas

This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.

Kinase Inhibitor

Targeted Therapy for Cancer

Recruiting1 awardPhase 2

Fort Smith, Arkansas

This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

Recruiting2 awardsPhase 3

Jonesboro, Arkansas

This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.

Corticosteroid

Hormone + Radiation Therapy with TAK-700 for Prostate Cancer

Recruiting2 awardsPhase 3

Kansas City, Missouri

This trial is studying the use of hormone therapy, including TAK-700, together with radiation therapy to see how well it works in treating patients with prostate cancer.

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Conditions

Locations

Psychology Related

Treatments

Cities

Prostate Cancer Clinical Trials in Kansas City, MO

Trials in Kansas City, Missouri

Enzalutamide +1 More

Antiandrogen

This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.

PF-06821497

BCL-2 Inhibitor

This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.

Carboplatin +1 More

Alkylating agents

This trial is comparing the efficacy of two treatments for patients with metastatic castrate resistant prostate cancer who have tumors containing BRCA1, BRCA2 or PALB2 inactivating DNA mutations.

Recombinant EphB4-HSA Fusion Protein +1 More

This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.

CAN-2409 Immunotherapy

Cancer Vaccine

This trial is testing CAN-2409, a treatment that kills prostate cancer cells and boosts the immune system to fight the cancer. It targets patients with localized prostate cancer. The treatment aims to improve their health outcomes by helping their immune system attack the cancer.

Enzalutamide

Antiandrogen

This trial is to study the long-term safety of subjects who are still benefiting from treatment with Enzalutamide.

Enzalutamide

Antiandrogen

This trial is testing a new drug to treat prostate cancer that has not spread. They will be testing how well it works and if it is safe.

AMG 509

Protein Kinase Inhibitor

This trial is testing a new drug called AMG 509 in adults to see if it is safe and to find the best dose. The study will monitor how people react to different doses.

Hypofractionated Radiation

Radiation Therapy

This trial is testing if a new way of treating prostate cancer, ultra-hypofractionation, is effective and has less urinary side effects.

MRT-2359

Molecular Glue Degrader

This trial tests a new drug called MRT-2359 that breaks down a protein in cancer cells. It targets patients with certain types of previously treated cancers. The drug aims to destroy a protein crucial for cancer cell survival, potentially stopping or slowing the cancer.

Popular Filters

Phase 3 Trials

Antiandrogen

Enzalutamide + Leuprolide for Prostate Cancer

This trial will test whether adding the drug enzalutamide to leuprolide helps patients with high-risk prostate cancer that has come back after surgery or radiotherapy.

Antiandrogen

Enzalutamide for Prostate Cancer

This trial is testing a new drug to treat prostate cancer that has not spread. They will be testing how well it works and if it is safe.

Antiandrogen

Apalutamide for Castration-Resistant Prostate Cancer

This trial will test whether apalutamide can help treat prostate cancer that is not responding to hormone therapy and has not spread.

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.

Corticosteroid

Hormone + Radiation Therapy with TAK-700 for Prostate Cancer

This trial is studying the use of hormone therapy, including TAK-700, together with radiation therapy to see how well it works in treating patients with prostate cancer.

PARP Inhibitor

Talazoparib + Enzalutamide for Prostate Cancer

This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.

Trials With No Placebo

Antiandrogen

Enzalutamide + Abiraterone + Prednisone for Prostate Cancer

This trial is to study the long-term safety of subjects who are still benefiting from treatment with Enzalutamide.

Checkpoint Inhibitor

Nivolumab + Ipilimumab for Rare Cancers

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

sEphB4-HSA + Pembrolizumab for Cancer

This trial is testing a new cancer treatment that uses a fusion protein and an anti-PD1 antibody. There will be four cohorts of patients with different types of cancer, all of whom have not responded well to other treatments.

Kinase Inhibitor

Targeted Therapy for Cancer

This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.

Corticosteroid

Hormone + Radiation Therapy with TAK-700 for Prostate Cancer

This trial is studying the use of hormone therapy, including TAK-700, together with radiation therapy to see how well it works in treating patients with prostate cancer.

View More Related Trials

View more prostate-cancer clinical trials kansas-city

Frequently Asked Questions

Other Trials to Consider

niPGT-A

Depo-Medrol Injectable Product

Reduced Toxicity Ablative Regimen

Sotorasib

Lutathera

Placebo

Placebo